Fangzhou Inc., a prominent provider of AI-driven Internet healthcare solutions, has secured a coveted spot on the KPMG China Healthcare 50 list for its innovative approach in chronic disease management. The company’s expertise in AI-driven solutions has been acknowledged for “extending chronic disease management into the home, with trusted long-term care”. With China’s population aged 60 and above surpassing 320 million by the end of 2025, there is a growing demand for diversified and high-quality care services, prompting the evolution of the health and wellness sector in the country.
Fangzhou has strategically expanded its AI+H2H (Hospital-to-Home) smart healthcare ecosystem to provide professional healthcare services outside traditional hospital settings. By integrating its proprietary ‘XingShi’ Large Language Model (‘XS LLM’) into online consultations and health management, Fangzhou ensures continuous support for chronic disease patients. The company’s AI capabilities play a vital role in offering personalized health recommendations, medication guidance, health risk monitoring, and behavioral interventions for patients, while also automating administrative tasks for physicians to enhance patient care.
To cater to elderly users, Fangzhou has introduced senior-friendly features such as one-touch voice input and simplified user interactions on its digital healthcare platform. Additionally, AI-enabled follow-up services and health reminders aid patients in adhering to long-term treatments. By combining advanced AI technology with continuous healthcare services, Fangzhou aims to streamline the delivery of medical resources and create an integrated chronic disease management ecosystem to meet the needs of China’s aging population.
As China’s leading online chronic disease management platform, Fangzhou serves over 56 million registered users and 251,000 physicians as of December 31, 2025. Specializing in tailored medical care and AI-enabled precision medicine solutions, the company’s mission is to enhance the accessibility and quality of healthcare services for individuals across China.
Leave a Reply